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Abstract
Recent metagenomic studies have demonstrated that the overall functional potential of the
intestinal microbiome is rather conserved between healthy individuals. Here we assessed
the biological processes undertaken in-vivo by microbes and the host in the intestinal tract
by conducting a metaproteome analysis from a total of 48 faecal samples of 16 healthy
adults participating in a placebo-controlled probiotic intervention trial. Half of the subjects
received placebo and the other half consumed Lactobacillus rhamnosusGG for three
weeks (1010 cfu per day). Faecal samples were collected just before and at the end of the
consumption phase as well as after a three-week follow-up period, and were processed for
microbial composition and metaproteome analysis. A common core of shared microbial pro-
tein functions could be identified in all subjects. Furthermore, we observed marked differ-
ences in expressed proteins between subjects that resulted in the definition of a stable and
personalized microbiome both at the mass-spectrometry-based proteome level and the
functional level based on the KEGG pathway analysis. No significant changes in the meta-
proteome were attributable to the probiotic intervention. A detailed taxonomic assignment of
peptides and comparison to phylogenetic microarray data made it possible to evaluate the
activity of the main phyla as well as key species, including Faecalibacterium prausnitzii.
Several correlations were identified between human and bacterial proteins. Proteins of the
human host accounted for approximately 14% of the identified metaproteome and displayed
variations both between and within individuals. The individually different human intestinal
proteomes point to personalized host-microbiota interactions. Our findings indicate that
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analysis of the intestinal metaproteome can complement gene-based analysis and contrib-
utes to a thorough understanding of the activities of the microbiome and the relevant path-
ways in health and disease.
Introduction
During the last decade, many phylogenetic and metagenomic studies have revealed the vast
genetic diversity and coding capacity of the intestinal microbiome in human adults [1,2]. We
all harbour hundreds of microbial species, each carrying several thousands of genes and hence
the intestinal microbiome enhances our own coding capacity by at least a hundred fold. Intesti-
nal microbes are involved in many crucial functions, such as metabolizing food components
that escape uptake by the host, contributing to the degradation of mucus, and producing vita-
mins and a variety of metabolites, such as short chain fatty acids and other important signalling
molecules. Overall, the interactions taking place between the host and intestinal microbes, as
well as between the different species of microbes, may exert a profound impact on the host’s
health [3,4]. The type and amount of microbes contributing to these actions differ substantially
between individuals which means that the phylogenetic composition can be considered as kind
of a subjective fingerprint [5,6]. However, metagenomic studies have shown only limited differ-
ences between subjects. Strikingly, while our microbiota varies phylogenetically, metagenomic
analyses have revealed that at the highest functional level, such as in KEGG pathway maps, the
functional potential of the microbiome of healthy individuals remains very similar [7,8]. How-
ever, this does not imply that there is a similarity in the actual activity of the microbiota in
vivo, because this is affected by a variety of factors, including diet, host genetics, and health
status.
Two well-established functional approaches have been exploited to extend the genome-scale
analysis to activity based profiling: metatranscriptome and metaproteome analyses. Recent fae-
cal and ileal metatranscriptomic investigations have indicated that there are pronounced differ-
ences at the gene expression level in subjects with comparable metagenomes [9–11]. However,
bacterial and archaeal transcripts have short half-lives, in the order of seconds to minutes and
hence faecal RNA may not accurately capture the biological processes taking place in the intes-
tinal tract. In contrast to mRNA, proteins are more stable and may provide an interpretation of
activities along the whole digestive tract. In the absence of global enzymatic or physiological
approaches, metaproteomics, the study of all proteins in an ecosystem, has been applied to elu-
cidate the actual function of the intestinal microbiota [12]. This technique makes it possible to
monitor the activities of the host and microbes at the same time, and thus to study their mutu-
alistic interactions [13].
So far, intestinal metaproteomic studies have been carried out with 20 healthy individuals at
a maximum of two time points [13–16]. Functional differences based on proteins have been
studied in a dozen patients with strong perturbing factors such as Crohn’s disease or antibiotic
treatment, but no functional baseline for healthy subjects has ever been established [16–19]. In
general, functional differences between healthy individuals and their variation over time have
only been studied to a limited extent.
Here, we expand these earlier studies with a cohort of 16 healthy subjects who took part in a
placebo-controlled probiotic intervention trial and characterized the dominant functionalities
by conducting a comprehensive faecal metaproteome analysis. In this longitudinal trial, these
subjects were followed for six weeks and a total of 48 different faecal samples were taken;
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before, during and after the placebo or probiotic intervention, resulting in three analysis time
points. These were used to identify the temporally stable proteins in each subject, i.e. the indi-
vidual core, as well as the shared functions, i.e. the common core, to define a metaproteomic
baseline in healthy subjects. Moreover, we addressed the question of whether the microbial
composition can explain the microbial activities i.e. converging vs. diverging in terms of com-
position and function.
Materials and Methods
Ethical statement
The Ethics Committee of the Hospital District of Helsinki and Uusimaa approved the trial and
its protocol (Ethical protocol no HUS 3577E0/05; Fig 1). The trial is not registered in an inter-
national trial register. Written consent was given by the study participants prior to the start of
the study. Details of this trial have been published previously [20–22].
Study Design
The analysed samples were part of a randomized, double blinded intervention study testing the
effect of various probiotic strains on immune and metabolic functions in healthy adults [21].
We focused here on the intervention with the well-described strain, Lactobacillus rhamnosus
GG (ATCC 53103).
The trial consisted of a three-week run-in period, a three week intervention period and a
three week wash-out period. Faecal samples at the end of each period were collected and stored
at -20°C at home before transferring them within 24 hours to -80°C at the study centre. In this
article, the sample collected at the end of the run-in period is called time point (TP) 1, the sam-
ple at the end of the intervention period is TP2, and the sample at the end of the wash-out
period is designated TP3. During the intervention period study participants consumed each
day 250 ml of a fruit based milk drink with or without L. rhamnosus GG (6.2 × 107 cfu/mL
amounting to a daily dose of 1.55 x 1010 cfu). In the present analyses we selected samples for
which faecal material was left. Eight subjects of the placebo group and eight from the L. rham-
nosus GG intervention group were included (S1 Table). The reduction of the study subjects
due to sample availability resulted in a skewed age distribution between the placebo and LGG
group (medians of 30 and 49 years, respectively). The median body mass index (BMI) was 23.9
in the placebo group and 25.9 in the LGG group. The female:male ratio was 6:2 in the placebo
group and 5:3 in the L. rhamnosus GG group. As detailed in [21], trial participants kept a study
diary. These included reporting any intestinal symptoms, the use of antibiotics and the regular
use of probiotics (S2 Table). All individuals rated their health status as good, except for subjects
116 and 163 who described their health status as average.
Protein extraction
Proteins were mechanically extracted from faecal samples (125 mg) by bead beating essentially
as previously described [13]. Six cycles of bead beating (6.5 ms-1 for 45 seconds) were run on a
FastPrep 24 (MP Biomedicals). The samples were kept on ice during the required 5 min resting
period in-between the cycles.
1D gel electrophoresis and in-gel protein digestion
To reduce the complexity of the protein extract, the same 1D gel fractionation approach was
carried out as described in [13]. The 37 kDa and the 75 kDa band of a prestained marker (Pre-
cision Plus™ Dual Color, Biorad) was used to define the height for cutting the lane into three
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fractions. Only the middle part (~37–75 kDa), containing the abundant metaproteome (AMP)
was subsequently analysed. In order to control for possible run differences impairing reproduc-
ible cutting, one of the samples was run on all of the gels. Gel pieces were washed and proteins
reduced, alkylated, and tryptically digested (per sample 200 ng of trypsin sequencing grade,
Promega) overnight similarly as described in [23]. Following extraction from the gel-pieces,
peptides were vacuum dried and stored at -20°C until used. Dried peptides were resolved in 2%
formic acid and filtered through glass microfiber filters (Whatman; grade GF/C) for removal of
gel particles. The peptide elutes were desalted by using OMIX tips (Agilent Technologies).
After aspiring the samples 15 times, the peptides were eluted with 60% acetonitrile/2% formic
acid, dried and reconstituted with 1% formic acid prior to LC-MS/MS.
Liquid chromatography tandemmass spectrometry
Protein digests were analysed by LC-MS/MS on a nanoflow HPLC system (Easy-nLCII,
Thermo Fisher Scientific) coupled to a LTQ Orbitrap Velos mass spectrometer (Thermo Fisher
Scientific, Bremen, Germany) equipped with a nano-electrospray ionization source. The
mobile phase consisted of water/acetonitrile (98:2 (v/v)) and 0.2% formic acid (solvent A) and
acetonitrile/water (95:5 (v/v)) and 0.2% formic acid (solvent B). Ten μl of sample were injected
into LC-MS/MS equipment. Peptides were loaded onto a reversed phase precolumn (in-house
made, 2 cm long, 100 μm inner diameter) with solvent A and separated in a reversed phase
analytical column (in-house made, 15 cm long, 75 μm inner diameter). Both columns were
packed with Magic C18-AQ 5 μm 200 Å resin (Michrom BioResources Inc., Sacramento, CA,
Fig 1. Consort flowchart of trial with ethical protocol no HUS 3577E0/05.
doi:10.1371/journal.pone.0153294.g001
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USA). Peptides were eluted by using a step-wise gradient (2–20% solvent B for 70 minutes and
20–40% solvent B for 30 minutes at a flow rate of 300 nl/min).
Full scan for eluting peptides was acquired in the mass range of 300–2,000 m/z of the Orbi-
trap-detector with 30,000 resolution at 400 m/z, AGC target set to 1000000 and maximum
inject time set to 100 ms. Based on the results of the full scan, the 20 most intense ions were
fragmented by CID fragmentation (normalized collision energy of 35%, activation time of 10
ms and activation Q set to 0.25) and scanned on the LTQ linear ion trap (AGC target set to
5000 and maximum inject time set to 50 ms). An isolation width of 2 m/z was used for precur-
sor selection. Precursors whose charge state could not be determined or for which the charge
state was +1 were discarded from the MS/MS analysis. Precursors were dynamically excluded
for 30 s with a repeat count of one. Both MS and MS/MS scans consisted of one microscan.
MS scans were acquired as profile data and MS/MS scans as centroid data. The peaks were
extracted with the software proteome discoverer (Thermo Scientific) with default settings and
the resulting Mascot generic format (mgf) files are available at ftp://MSV000079596@massive.
ucsd.edu (generic password “a”).
Peptide identification
Peptide identification was performed as described previously [13] with a database extended for
the number of bacterial genomes and alternative human proteins (S3 Table). Peptide identifica-
tions were filtered with a false discovery rate (FDR) of 5%.
Functional and phylogenetic annotation of peptides
Functional annotation of peptides was performed by a BLAST search of the original protein
sequences against the Cluster of Orthologous Groups database (COGdb) as in [13]. In addition,
a BLASTP 2.2.27 search of the original protein sequences against NCBInr was performed. In
the KEGG Orthology (KO) retrieval, BLAST results were imported into the metagenomic data
analysis software MEGAN [24] (version 5.1.5; default parameters: maxMatches = 100, min-
Score = 50.0, maxExpected = 0.01, topPercent = 10.0, minSupport = 50).
A possible phylogenetic origin was assigned to a peptide by the same principle, as described
previously [13]. In brief, in order to achieve a successful taxonomic annotation a peptide was
required to have a complete peptide match in the universal protein resource knowledgebase
(UniProtKB) and in the case of multiple taxonomic hits per peptide the lowest common ances-
tor was reported. Instead of utilizing in-house Python scripts [13] the online tool unipept was
used [25] (version 1.4; settings: I and L equated, advanced missed cleavage option (trypsinized
peptides searched but results per miss-cleaved peptide combined), duplicates filtered).
In the quantitative analysis, spectra per peptide per class (COG, KEGG, phylogenetic level
etc.) were summed and relative percentages per sample calculated for heatmap visualization.
To assess the contribution of distinct functionalities in a certain domain, genus, or species,
the functionally and phylogenetically annotated spectra were queried for the taxonomic unit of
interest. To create a subset of the data containing peptides with a human origin and to investi-
gate the human functionalities in more detail, peptides with at least “Chordata” assignments
were picked. Selecting only Homo sapiens specific peptides would have resulted in very few
hits, due to the wide range of Chordata species with highly similar homologous sequences. Bac-
terial KOs were mapped onto microbial gut-specific metabolic modules (GMM), its syntax is
provided in the supplement in [26]. The GMM presence is defined with a threshold of detec-
tion of more than two thirds of the KOs involved in one of the alternative metabolic pathways
covered by a module (i.e. coverage > 2/3). The GMM abundance is defined as the median KO
abundance in the maximum coverage alternative pathway, if coverage> 2/3.
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Rarefaction analysis
KO counts for the lowest functional level (i.e. fourth) were used for analysing how the numbers
of found KOs change as a function of number of samples. All samples per individual were com-
bined and the results of a rarefaction analysis including all possible combinations both for
accumulated (KO rarefaction) and shared KOs (KO core) were plotted. The analysis was per-
formed at intervals ranging from two to 16 samples. At each interval, 1000 bootstraps were
taken from the samples, and the numbers of KOs present in one or more of the samples
included in a bootstrap were counted. A similar analysis was performed by counting the num-
ber of KOs present in all of the samples included in a bootstrap. This resulted in an estimation
of sampling distribution of KO counts at varying levels of sample numbers. The analysis was
performed with R v.3.1.1.
Phylogenetic analysis: microarray and quantitative polymerase chain
reaction (qPCR)
Extraction of DNA was performed with the Promega kit; this involved homogenization of the
faecal material with ample amount of 1x PBS and continuing DNA extraction with the pellet as
described in [27]. A phylogenetic microarray (Agilent Technologies), the Human Intestinal
Tract Chip (HITChip), was applied to analyse the phylogenetic composition based on 16S
rRNA gene amplicons [28]. Hybridisation of the microarray and min-max signal normaliza-
tion were performed as described [29]. Per target sequence the oligonucleotide probe signals
were summed [30]. Throughout this study, relative abundances are provided at either the phy-
lum- or the genus-like level. The genus-like level microarray data are provided in S4 Table. In
addition to microarray analysis, qPCR of 16S rRNA regions was carried out to determine the
total amount of bacteria, Bacteroidetes, Bifidobacterium spp. and Lactobacillus spp. present in
1g of faeces using taxa-specific primers as described previously [31]. The presence of archaeal
DNA was analysed with qPCR, using primers specific forMethanobrevibacter [32].
Statistical data analysis
The statistical programming language R was used for statistical data analysis [33]. Hierarchical
clustering using complete linkage algorithm and the Jaccard distance between identified pep-
tides was used to determine the dissimilarity of the metaproteome [34]. Hierarchical clustering
(complete linkage) was also applied to the oligonucleotide profiles using 1-Pearson’s correla-
tion coefficient (r) as the similarity measure.
Split violin plots (R package vioplot and http://mbjoseph.github.io/blog/2013/06/24/violin/)
were used to visualize the distribution of relative abundances of bacterial phyla both for phylo-
genetic microarray and proteomic data.
To identify correlations between human and bacterial functional classes, Spearman correla-
tion was applied, and the R package qvalue was used for calculating false discovery rate adjusted
p-values (q-values). Results were filtered for a q-value< 0.05.
Results
Microbial and human proteins in the cohort reveal specific core functions
The analysis of the metaproteome of 48 faecal samples obtained at the three time points, from
each of the 16 subjects, which had been selected from the probiotic and placebo groups (Fig 1),
resulted in approximately 1 million mass spectra of which 213,855 (23.7%) could be identified
(FDR< 5%) (S5 Table). Because of the ambiguity in mapping the peptides to distinct proteins
—the so-called protein inference—that is especially noticeable in metaproteomics, we have
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compared samples based on their spectral counts per functional group and not per protein
[12,35].
Functional annotations provided a COG or KO assignment for 78% of the identified spectra.
In addition, we could assign a taxonomic origin according to the lowest common ancestor
principle to 66% of the identified peptides, of which 80.9% were classified as bacterial, less than
1% as archaeal, and 13.8% as eukaryotic. The remaining 5.3% could not be assigned to a single
domain as the peptides could be found in at least two domains of life. The differentiation
into bacterial and eukaryotic/human peptides was utilized for determining domain-specific
functionalities.
Overall, 967 different bacterial KOs were identified. Rarefaction analysis of the functional
diversity across the 16 individuals (S1 Fig) showed that more than half of these bacterial KOs
were already covered when combining the analysis of three individuals. A core of around 200
KOs was identified in any pair of two subjects and around 100 KOs were found in each of the
individuals.
It was decided to concentrate on relevant intestinal functions and focus on those proteins
present in the highest amounts. Therefore, we chose those KOs for which at least five spectra in
one of the samples across the 48 samples had been identified (S6 Table). From these 238
remaining KOs, the 25 most abundant bacterial ones were identified in all of the samples, rep-
resenting the most stable and abundant core functions (Fig 2). Glutamate dehydrogenase was
found as the most abundant intestinal functionality (on average 7% of the spectra) in healthy
individuals, as reported previously [13]. Other abundant proteins included major glycolytic
enzymes as well as specific sugar-converting enzymes such as L-fucose isomerase, L-arabinose
isomerase and glucuronate isomerase. The 238 bacterial KOs were mapped onto microbial gut-
specific metabolic modules (GMM). A total of 21 out of 102 modules was detected as being
enriched (S7 Table). With an average enrichment of 38 spectra the arabinose module was
found to be extensively represented in all subjects at all time points. With respect to the COG
family level, the metaproteomes appeared to be very similar (Fig 3). The COG families for car-
bohydrate transport and metabolism, energy production and conversion and amino acid trans-
port and metabolism were the most representative families in all of the samples. Despite the
rather even distribution of COG families across the samples, individual patterns were clearly
discernible. These included a relatively higher level of COG family L (Replication, recombina-
tion and repair) in the samples of subjects 106, 137 and 124. Moreover, a clear difference could
be observed in those peptides to which no COG family could be assigned, highlighting the
importance of further studying these unassigned hits.
A total of 134 human KOs was identified. We selected those KOs with at least two spectra in
one of the samples across the 48 samples, which resulted into 73 KOs (S8 Table). From these,
the most abundant 15 KOs represented functions involved in digestion and host protection,
and these showed specific patterns among all subjects and time points (Fig 2). Proteases and
peptidases accounted for an average of 23% of the 73 most abundant human KOs. Carbohy-
drate and lipid-degrading enzymes were less abundant.
Correlation analysis of the human and bacterial KOs revealed 138 potentially relevant corre-
lations (p-value and q-value< 0.05, S2 Fig). These included significant positive correlations
between the human interacting serine/threonine-protein kinase 4 (K08848) and the bacterial
flagellar hook protein FlgE (K02390), i.e. evidence for the presence of flagellins; between
human alpha-amylase (K01176) and bacterial putative ABC transport system substrate-bind-
ing protein (K01989), propionate CoA-transferase (K01026), ATP-dependent Clp protease
ATP-binding subunit ClpB (K03695), and cytidylate kinase (K00945), as well as a negative cor-
relation between the antimicrobial protein DMBT1 (K13912) and the bacterial bleomycin
hydrolase (K01372). Another indication for specific host-microbiota interactions may be
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deduced from the identification of an enrichment of degradation of the host-derived glycan
mucin in at least two samples of four subjects (107, 119, 147, and 155) when mapping the bac-
terial KOs onto GMM.
Evidence for a personalised and stable functional microbiome
A subject-specific clustering of all 16 subjects was observed when the identified peptides were
used for hierarchical clustering based on Jaccard similarity (Fig 4). Moreover, also based on
KO abundances (at least 5 spectra in one sample), virtually all of the samples clustered accord-
ing to the individual subject (S3 Fig). This indicates that the functional microbiome is personal-
ised and represents an extension of the compositional individuality that has been described
previously and is now confirmed here (S4 Fig). Similarly, when comparing the peptide-based
and the phylogenetic oligonucleotide-based hierarchical clustering in more detail, we observed
that the samples obtained from subject 135 were quite distant from the other samples. How-
ever, in the peptide hierarchical clustering the samples of subject 119 were even more different
than those of subject 135. This indicates that the proteins of subject 119 are rather unique
and may reflect an aberrant health status and/or antibiotic use, as reported by this subject
(S2 Table).
To compare the individual metaproteomes on a functional level, we studied the individual
differences of certain gut-specific KOs (Fig 5). The proteins involved in the production of
short chain fatty acids (SCFA) are of interest due to the multitude of beneficial roles that
SCFAs play in the intestine. The average levels for the KO for butyryl-CoA dehydrogenase, an
enzyme involved in the production of butyrate, varied from 0.2% to 1.4% in the subjects. For
Fig 2. Top 25 bacterial (upper panel) and top 15 human (lower panel) functional categories (KEGG). (white to dark red range for bacteria KOs are from
0.1 to 10.2% out of 238 bacterial KOs and for human KOs from 0.0 to 49.3% out of 73 human KOs). The samples are organized according to treatment group
(left: placebo group, right: probiotic group); sample time points are abbreviated as 1 (sample collected at the end of the run-in period), 2 (sample collected at
the end of the intervention period) and 3 (sample collected at the end of the wash-out period).
doi:10.1371/journal.pone.0153294.g002
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methylmalonly CoA mutase, a key enzyme in propionate synthesis, levels varied from less than
0.1% to 1.2%. In general, the levels of KOs involved in butyrate synthesis were higher than
those for proprionate (with butyryl-CoA dehydrogenase plus 3-hydroxybutyryl-CoA dehydro-
genase and methylmalonyl-CoA mutase as proxies). For two subjects (119 and 155), similar
amounts of both pathways were found (S5 Fig). Flagellins are signalling ligands of the toll like
receptor (TLR) 5 and thus they represent microbial proteins that communicate with the host.
This class of protein varied in the subjects from 0.2% to 1.6% (Fig 5).
The predominantly anoxic environment in the colon and other parts of the intestinal tract
requires that the intestinal microbiota have to exploit anaerobic strategies for dealing with elec-
trons. It was predicted that pyruvate-flavodoxin oxidoreductase might contribute to an anaero-
bic electron sink and this protein class showed a distribution varying from 0.4% to 2.9%.
Sirohydrochlorin cobaltochelatase, an enzyme involved in the anaerobic biosynthesis of cobala-
min (vitamin B12), contributed between 0.1% and 1.0% to the 238 most abundant KOs.
The consumption of LGG did not exert any effect on the identified peptides nor on the
KEGG profiles (Fig 2; S3 Fig) i.e. the probiotic intervention did not lead to a systematic change
of the identified peptides and their associated function. Since we tested this hypothesis with dif-
ferent statistical methods, we are confident that we did not detect functional differences. When
Fig 3. Relative distribution of COG families across samples. The samples are organized according to treatment group (left: placebo group, right: probiotic
group); sample time points are abbreviated as 1 (sample collected at the end of the run-in period), 2 (sample collected at the end of the intervention period)
and 3 (sample collected at the end of the wash-out period); ambiguous = functions being part of more than one COG family; [G] Carbohydrate transport and
metabolism; [E] Amino acid transport and metabolism; [C] Energy production and conversion; [I] Lipid transport and metabolism; [R] General function
prediction only; [O] Post-translational modification, protein turnover, and chaperones; [M] Cell wall/membrane/envelope biogenesis; [S] Function unknown;
[P] Inorganic ion transport and metabolism; [H] Coenzyme transport and metabolism; [Q] Secondary metabolites biosynthesis, transport, and catabolism; [F]
Nucleotide transport and metabolism; [J] Translation, ribosomal structure and biogenesis; [L] Replication, recombination and repair; [F] Nucleotide transport
and metabolism; [K] Transcription; [V] Defense mechanisms; [D] Cell cycle control, cell division, chromosome partitioning; [T] Signal transduction
mechanisms; [Z] Cytoskeleton; [U] Intracellular trafficking, secretion, and vesicular transport.
doi:10.1371/journal.pone.0153294.g003
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calculating the ratio of bacterial to eukaryotic assignments, we did notice an increase during
and a decrease after the intervention in the LGG group such that the samples from the LGG
group clustered significantly together (S6 Fig; Pearson correlation; Fisher exact test p-value:
0.04). While this may point towards a decreased level of faecal host proteins in the LGG inter-
vention group, stringent statistical analysis between the ratio of bacterial/eukaryotic peptides at
time point one versus time point two in the LGG group did not reach statistical significance
(p = 0.08).
Variation in human proteins
The three most abundant human KOs were the starch-degrading enzyme alpha-amylase (aver-
age 11.7%), the serpin alpha 1 antitrypsin (10%) and the hydrolase alkaline phosphatase
(6.1%); these revealed differences across and within individuals (Fig 2). The levels of alpha-
amylase differed substantially between individuals. Relative abundances reached almost 50% at
Fig 4. Hierarchical clustering of Jaccard similarity indexes of identified peptides. The peptide profiles clustered according to each subject however not
according to the treatment group. The samples from subject 119 differed the most and 135 the next most from the rest of the samples (at a distance measure
of 0.9 and just below, respectively); labels: Subject—time point; 1: sample collected at the end of the run-in period, 2: sample collected at the end of the
intervention period, and 3: sample collected at the end of the wash-out period; black font: placebo group, blue font: probiotic group.
doi:10.1371/journal.pone.0153294.g004
Fig 5. Heatmap of KEGG functions with marked differences between subjects. (white to dark red range for bacteria KOs are from 0.0–4.3% out of 238
bacterial KOs). The samples are organized according to treatment group (left: placebo group, right: probiotic group); sample time points are abbreviated as 1
(sample collected at the end of the run-in period), 2 (sample collected at the end of the intervention period) and 3 (sample collected at the end of the wash-out
period).
doi:10.1371/journal.pone.0153294.g005
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TP2 and TP3 in subject 106, but were consistently low (4–6%) in subjects 135 and 137. Nota-
bly, low alpha-amylase levels co-occurred with high levels of Prevotella spp. (see below).
High levels of alpha 1 antitrypsin of 10% were found in the majority of the samples with a
minimum of 4.5% and a maximum of 18.4% of the human spectra.
Phylum origin of 16S rRNA genes and peptides
A phylogenetic 16S rRNA gene based microarray (HITChip) was used to assess the microbial
composition of the studied faecal samples. The average diversity (Shannon index) was 5.89
(min: 5.54, max: 6.3) in line with normal diversity observed in adults as observed in the in-
house HITChip database with more than 1000 adult samples, which has been described previ-
ously [36]. The oligonucleotide profiles clustered according to subjects (S2 Fig). However,
temporal variation was observed both at the phylum- and genus-like phylogenetic levels (S9
Table).
On average, more than 99% of 16S rRNA gene signals and MS/MS spectra with microbial
assignment could be assigned to the four phyla Firmicutes, Bacteroidetes, Actinobacteria, and
Proteobacteria in descending abundance (Fig 6; data per sample in S7 Fig). The three main
phyla varied extensively throughout all samples for both measurements. For example, Actino-
bacteria varied from below 1% to over 15% both for 16S rRNA gene and proteomic measure-
ments. When compared to the 16S rRNA gene data, there were less Firmicutes MS/MS
assignments but more Actinobacteria and Bacteroidetes MS/MS assigned. The distribution of
Proteobacteria was rather similar with the HITChip and proteome data. Verrucomicrobia, the
fifth most abundant phylum, had a slightly higher representation on 16S rRNA gene than at
the peptide level. Looking at the ranking of the phylum the microarray and metaproteomic
analyses agreed with the order of Firmicutes, Bacteroidetes, Actinobacteria, Proteobacteria,
and Verrucomicrobia.
A high correlation (Pearson correlation coefficient of 0.67 at a q-value below 0.05) was
found between phylogenetic microarray signals and spectral counts for Actinobacteria.
Fig 6. Distribution of the five main phyla in the studied cohort on 16S rRNA and peptide level. The split violin plots present side by side the relative
amount (in percentage) of Firmicutes, Bacteroidetes, Actinobacteria, Proteobacteria and Verrucomicrobia obtained by 16S rRNA gene analysis (violet) and
the metaproteomic measurements (blue). Both distributions are based on all 44 samples for which both 16S rRNA and metaproteomics data were available.
The lines denote the median of the distributions (based on all the measured samples with the two different techniques) and the bar represents the 0.25 to
0.75 quantile.
doi:10.1371/journal.pone.0153294.g006
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Bacteroidetes and Firmicutes correlated negatively, at the phylogenetic microarray level as well
as at the peptide level. However, in general, the Bacteroidetes peptide assignments were higher
than the 16S rRNA gene measurements and only in a few cases was the phylogenetic array sig-
nal higher than the ratio of assigned peptides (S7 Fig). In addition, the Bacteroidetes microar-
ray signals displayed more differences between the three time points, whereas the Bacteroidetes
levels determined by taxonomic assignment of the identified peptides were rather stable. To
control for possible bias originating from the microarray measurements, Bacteroidetes qPCR
was carried out and these results confirmed the phylogenetic microarray data. The abundance
of the most common intestinal methanogen i.e. the EuryarchaeonMethanobrevibacter smithii,
was estimated by performing qPCRs; in 12 of the 44 samples more than 108 16S rRNA gene
copies/g of faeces were detected. For five of these 12 samples, the Euryarchaea-specific peptide
assignments were higher than 0.1% of the phyla assignments. In general, within 10,000 pep-
tides with an assigned taxonomy, only about four Euryarchaea peptides were identified, with
the exception of sample 135–3 in which almost 1% of peptides with a phylum assignment were
of Euryarchaeal origin. Fungal peptides were identified at a similarly low level and around 4
out of 1000 spectra with taxonomic information were found to derive from plants (data not
shown).
Plotting the COG assignments per phylum revealed a similar pattern as that previously
observed with a smaller set of samples (S8 Fig) [13]. More than 59% of the Actinobacteria spec-
tra were grouped to the category of Carbohydrate Metabolism, highlighting the impact of that
phylum on sugar utilization and transport. Almost 50% of the Bacteroidetes spectra had no
assigned function, emphasizing the further need for bacterial physiological studies to explore
these unknown encoded functions.
Pathways of prominent and distinct gut microbes
The most prominent microbial species in general (on average constituting 15% of the micro-
biota measured by 16S rRNA gene analysis) was Ruminococcus obeum, a well-known represen-
tative of the largest phylum Firmicutes. However, on average, only 1.6% of the bacterial
peptide hits classified at least to a phylum assignment were specifically assigned to R. obeum,
hampering comparisons between samples. In contrast, the second most abundant species
based on phylogenetic data, Faecalibacterium prausnitzii (constituting around 10% of the
microbiota assessed by microarray measurements), represented on average 9.8% of the spectra.
Therefore, we further analysed the distribution of F. prausnitzii and its activities. Bacteria
related to F. prausnitzii showed substantial variation across subjects and time points at the 16S
rRNA gene level (S9 Fig). For some subjects, 16S rRNA gene and proteomics measurement dis-
played essentially the same trend (e.g. samples of subjects 104, 106, 112) but for some samples,
the 16S rRNA gene and peptide measurements developed in the opposite directions. In particu-
lar, subject 137 was a standout example where F. prausnitzii was found to contribute less than
5% to the overall community, whereas its metaproteome exceeded more than 10% of all pro-
teins, indicative of the very high gene expression activity of this bacterial group. The majority
of the F. prausnitzii KOs were involved in amino acid metabolism, but almost half of the F.
prausnitzii peptides could not be designated to any specific function. The analysis of F. praus-
nitzii’s functional variation showed a certain trend within individuals (Fig 7). For example,
glucuronate-isomerase was detected in relatively high amounts across all samples with few
exceptions. In subjects 119 and 147, very low levels of lactose/L-arabinose transport system
substrate-binding protein were observed.
For the second largest phylum Bacteroidetes species-specific spectra were much less abun-
dant than for the above-mentioned dominant Firmicutes. This was also found for the spectra
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of Prevotella spp., which in contrast to Bacteroides, are believed to be more prevalent in individ-
uals consuming fiber-rich diets. For example, Prevotellamethylmalonyl-CoA mutase was
found in all of the samples of subject 162, indicating stable Prevotella-specific propionate syn-
thesis in that individual (S10 Table). Prevotellamicroarray signals were around the mean of 1%
but for subjects 130 and 135 they were up to 20%. For all the samples of these two individuals,
several hundreds of Prevotella-specific peptides were identified especially for carbohydrate
degrading enzymes (S10 Table). In addition, low levels of human alpha-amylase were found in
the samples of these individuals. This may hint that high amounts of complex carbohydrates
were part of these individuals’ diets and left for Prevotella to degrade.
Since Actinobacteria, the third largest phylum, have a distinctive lifestyle in the intestine, i.e.
specialization in the utilization of complex carbohydrates, we attempted to clarify whether
there would be any detectable intra-individual differences within this phylum. We found that
Actinobacterial xylose isomerase was missing from the samples from individuals 119 and 135.
There was variation in the amounts of Actinobacterial beta-fructofuranosidase between indi-
viduals, for example, low levels were detected in subjects 107 and 135 (S10 Table).
Some differences were found in the abundances of Proteobacteria KO, the fourth largest
phylum in this study. Proteobacterial thioredoxin 1 was found in all of the samples but at a
very low level. A subject-dependent pattern was found for Proteobacterial taurine-pyruvate
aminotransferase (S10 Table). This enzyme mostly originated from Bilophila, a genus found to
be present in a large proportion of the population and which produces sulphide from taurine
[37]. Taurine has multiple roles in humans, such as the formation of bile salts, and Bilophila
spp. may be involved in a balanced turn-over [38].
In the samples with relatively high levels of archaeal proteins (from subjects 135-2/3, 162–3)
KOs involved in methane metabolism were detected, most prominently the methyl-coenzyme
M reductase beta subunit (S11 Table).
Discussion
Metaproteome analysis is a recently developed approach to identify at the protein level the
highly expressed genes in an ecosystem [12,39].
Here, we studied the faecal metaproteome of 16 healthy Finnish adults who took part in a
probiotic intervention and consumed a fruit-based drink with or without L. rhamnosus GG by
sampling at three time points over a period of six weeks and found that the functional micro-
biome is both personalized and stable over time. Addressing bacterial, archaeal and human
proteins, we were able to provide a state of the art overview of the activities of both the intesti-
nal microbiota and the host.
Functionality of the gut ecosystem
Around 10% of the identified microbial KO functions were found to be present in all the indi-
viduals; these represent the core of the intestinal ecosystem with carbohydrate transport and
Fig 7. Heatmap of selected KOs assigned to F. prausnitzii. (white to dark red range for 0.0–29.4% out of 123 F. prausnitzii specific KOs). The samples are
organized according to treatment group (left: placebo group, right: probiotic group); sample time points are abbreviated as 1 (sample collected at the end of
the run-in period), 2 (sample collected at the end of the intervention period) and 3 (sample collected at the end of the wash-out period).
doi:10.1371/journal.pone.0153294.g007
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metabolism, energy production and conversion and amino acid transport and metabolism
being the most prominent metabolic routes. Obviously, by analysing the metaproteome of 16
subjects there is not yet a saturation of identified functions but by adding more individuals
more functions will still be identified. The identification of several sugar-converting enzymes
in the core metaproteome is indicative of the microbiome’s ability to exploit glycans as a rap-
idly available energy supply. The observation that the arabinose module was found to be
enriched in all individuals might be attributable to the fact that Finnish subjects are known to
consume large amounts of fibres, specifically those derived from rye, which also contains arabi-
nose [40–42].
Similar to the microbial core functions, also a core of the host functions could be detected.
The most prominent biological activities found in the host core were proteinases and pepti-
dases, indicative of high intestinal proteolytic activity or the high stability of these proteins,
since only free amino acids and di- and tri-peptides are transmitted to the blood stream in the
intestine. However, these proteinases and peptidases may also be acting on different routes and
may possess signalling activities.
Other host core proteins included important functions such as the starch-degrading enzyme
alpha-amylase (average 11.7%), the serpin alpha 1 antitrypsin (10%) and the hydrolase alkaline
phosphatase (6.1%); these enzymes displayed differences not only between but also within the
same individuals (Fig 2).
Personalized and stable functional intestinal microbiome
We found that each adult contained a unique faecal metaproteome that was stable over the
analysed period of six weeks. Therefore, compositional individuality was conserved at the func-
tional level, suggesting that a distinctive set of microbes may be responsible for a specific distri-
bution of functions. Further studies will be required to identify the factors involved. Most
likely, host genes together with environmental factors (diet, drugs, hygiene setting) may prime
the ecosystem to develop its individuality. The presence of a personalized functional micro-
biome was suspected based on peptide assignments and KO abundances. Thus, there seems to
be a functional stable metaproteome and sequence differences (as detected at the peptide level)
due to different microbial communities may not solely explain the clustering of the subjects. A
comparison of the clustering at the oligonucleotide and peptide level could suggest that there is
stronger individuality at the phylogenetic level in comparison to the metaproteomic data.
However, this observation can be partly explained by the difference in the type of measurement
and the subsequent difference in the applied distance measure (Jaccard similarity for peptide
measurements versus Pearson’s correlation for microarray data). The developed metaproteo-
mics approach is an a-priori non-defined approach i.e. identified peptides depend on sample
(and not each time the very same peptides in one protein get analysed) whereas the microarray
is an a-priori defined approach: i.e. each sample is tested against a fixed set of oligonucleotides.
Individual differences in functions can be very important for the intestinal ecosystem such
as the observed large variations in butyrate production or flagellin generation (Fig 5). Notably,
one subject (155) had low spectral counts for both butyryl-CoA dehydrogenase and flagellin,
both assigned to the Firmicutes. Higher gene counts for flagellar assembly in combination with
a higher abundance of members of the phylum Firmicutes were found in a Russian cohort
when compared to a Western cohort [43]. The authors concluded that differences in diet i.e. a
higher consumption of resistant starch in rural Russian areas, might account for these results.
Glucuronate isomerase was among the most abundant 25 functional classes and showed vari-
ance between the individuals in this study; an earlier study described that the gene for this
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enzyme was present in similar amounts but differed highly in its expression levels across indi-
viduals [10].
We detected variations in the levels of an enzyme (sirohydrochlorin cobaltochelatase)
involved in the anaerobic synthesis of vitamin B12. An accumulation of the genes involved in
B12 cobalamin synthesis has been found in the intestinal microbiota of adults compared to
infants [44]. Our data suggest that there might be factors other than age influencing vitamin
B12 synthesis.
The observed differences in sugar metabolism, such as the absence of xylose isomerase
derived from Actinobacteria in some subjects, may point to a diet lacking the respective sub-
strates. However, as we do not have dietary records of the study participants, causal explana-
tions for the individual as well as temporal differences between the faecal metaproteomes
cannot be provided.
We did not detect any obvious functional differences in the faecal metaproteome following
the probiotic intervention as compared to the placebo. This is in line with our previous results
from the same cohort i.e. the LGG intervention did not change the overall composition of the
faecal microbiota; only the amount of Lactobacilli (reflecting the ingested strain) differed sig-
nificantly after the intervention [22]. With LGG representing only up to 0.1% of the total faecal
community in the post-intervention samples, it is not surprising that LGG-specific proteins
were hardly detected. However, immunological differences between the two groups have been
detected [21], evidence that the probiotic product did exert some effects. Rather than colon
that represents the predominant source of faecal material, it is more likely that differential pro-
tein expression after LGG intake takes place in the ileum which is a region of the gut less
densely populated with bacteria and a more active site of signaling. It remains possible that the
changes at the protein level in the gut lumen (versus intra-mucosal) are too subtle to be mea-
sured with the MS approach used here: i.e. data dependent MS analysis. However, there was a
trend that the ratio of bacterial/eukaryotic peptides was increased in the LGG group.
Previously, comparative studies on faecal metaproteomes have been conducted between
healthy and diseased subjects. These kind of studies in which an intact and pathologically per-
turbed intestinal ecosystems have been compared to each other represent much more drastic
phenotypic differences than present in our study and may explain the lack of clear differences
observed in our cohort [17,18]. In a comparison of the microbial profiles and metaproteomes
of healthy and Crohn’s Disease (CD) patients, CD patients could be distinguished from the
healthy controls based on their 2-DE proteome profiles [18].
Human-bacterial interactions as assessed by metaproteomics
We were especially interested in intestinal proteins which could serve as a strong indication for
the presence of host-microbiota crosstalk. Therefore, we correlated the spectral counts of
human and bacteria derived KOs and identified several significant associations. These protein
families included the pair of human derived receptor-interacting serine/threonine-protein
kinase 4 and the bacterial flagellar hook protein FlgE. This could be one example of a human-
microbe interaction in the gut as the human kinase is involved in signalling to elicit an inflam-
matory response for which flagellins, via TLR5 signalling, could be the stimulus. Human alpha-
amylase correlated significantly with the functional families of bacterial putative ABC transport
system substrate-binding protein, propionate CoA-transferase, ATP-dependent Clp protease
and cytidylate kinase. These correlations could reflect the interdependence regarding nutrient
resorption and utilization between host and microbes. Moreover, a negative correlation was
observed between the antimicrobial protein DMBT1 (deleted in malignant brain tumors 1 pro-
tein) also termed SALSA and known to be present in large amounts in faeces already in early life
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[45], and a bacterial, amino-peptidase (bleomycin hydrolase). This finding may point to a physi-
cal human-bacterial-protein interaction or to an indirect interaction as agglutination of some
other molecule to DMBT1 may suppress the expression of the aminopeptidase.
In addition to the identified correlations, we observed relatively high levels of L-fucose
isomerase. As fucose is a typical component of many O- and N-linked glycans produced by
mammalian species rather than by plants, its use by the intestinal microbiota is a further indi-
cation for a mutualistic interaction between host and microbes. Recently, modulation of the
fucosylation of mucus proteins was claimed to act as a physiological mechanism to provide the
microbiota with substrates in case of disease [46] and an absence of fucosyl transferase as is the
case in non-secretor subjects, was associated with a distinctive intestinal microbiota composi-
tion with reduced levels of mucus-degrading bacteria, including Bifidobacterium and Akker-
mansia spp. [29]. Here, we could not identify any association between the abundance of L-
fucose isomerase and any specific microbial groups.
Activity of specific microbial groups
The rationale behind studying the metaproteome is that microbial composition and their gene
content alone may not be sufficient to explain a certain phenotype. Therefore, we compared
the metaproteomic data with the phylogenetic data generated from a microarray. In general,
the observations based on the 16S rRNA gene and organism-origin of peptides were often in
agreement. However, in some instances, this was not the case and this may reflect the level of
biological activity of the specific microbial group. These detected differences between the
microbial composition and protein-makeup add further evidence to earlier findings that phylo-
genetic profiles alone cannot reflect changes in the functions being expressed by the micro-
biome. In a study where metaproteomic profiles of healthy and CD patients were compared,
differences in the amounts of certain proteins were observed although the abundance of corre-
sponding species behaved in a different manner [18].
In this study, we found the amount of Firmicutes in our microarray data to be 1.2 times
higher than that inferred from the metaproteomic data, even though the phylogenetic and
proteomic measurements for the prominent representative species F. prausnitzii were in good
agreement. These findings could indicate that Firmicutes proteins may be under-represented
in the protein sequence database, so that they get relatively less identified, but F. prausnitzii is
at least biologically as active as its presence would indicate. In our earlier study, the abundances
for Firmicutes were the same but in contrast to the current findings we identified less Bacteroi-
detes at the peptide level than with the microarray [13]. The difference might be explained by
the higher amount of samples. The ratios obtained for Bacteroidetes differ widely between
studies partly due to different extraction efficiencies of the DNA extraction protocols being
used [32]. The average relative abundance of 10% found here is at the lower end of the range
reported for Bacteroidetes [47] but in the same range as in another Finnish cohort [5] and in a
Chinese cohort [48]. We cannot exclude the possibility that the “overrepresentation” of Bacter-
oidetes peptides may reflect their potential underrepresentation in the DNA preparations as in
our earlier study where we found relatively less Bacteroidetes peptides compared to the micro-
array data a different DNA extraction method, i.e. repeated bead beating, was applied. How-
ever, as the fluctuations seen at the microarray level were not observed at the peptide level, it
might well be that we detected an actual difference in presence and protein production in
Bacteroidetes. On the other hand, the observation may also be explained by the fact that exten-
sive DNA transfer has been found in Bacteroidales species leading to a homogenous gene
content across species [49] that may facilitate the identification of Bacteroidetes peptides in
comparison to the more heterogeneous Firmicutes peptides. As the Bacteroidetes qPCR results
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corresponded well to the microarray measurements, a bias due to underrepresentation of cer-
tain taxa on the microarray seems unlikely.
The lower relative proportion of Verrucomicrobia in the MS/MS data versus 16S rRNA
gene data may be due to an abundance issue, limiting the analysis of proteins of a phylum
which contributed only around 1% to the overall microbiota. In an earlier study, we found a
high number of Verrucomicrobia peptides but then also the measured DNA reads were well
above 1% [15]. The peptide and qPCR results for Methanobrevibacter were also in good agree-
ment with each other. The high correlation of the levels of 16S rRNA gene and protein mea-
surement for Actinobacteria gave an indication for an association between the abundance and
biological activity of corresponding taxa and also provided an assurance of the reliability of
these measurements.
In summary, on one hand, our data allows us to conclude that proteomic data in general
reflects phylogenetic composition but on the other hand, it highlights distinct activities and
possibly to some extent, analytical bias such as cross-hybridisation and DNA extraction bias.
Although today the taxonomic assignment of peptides is possible, due to the far from complete
coverage in databases, the assignment is not perfect. Therefore, the technical and annotation
issues noted here may explain the results to some extent; this is a limitation of all other meta-
omics studies [50].
Human proteins in faecal samples—relation to health
Specific human proteins in faeces have been used as markers for certain physiological condi-
tions [51] but from a metaproteomic perspective, differences in gut-derived host proteins have
not been studied extensively. Therefore, we also studied the variations in the proteins of the
host as the applied approach identifies both microbial and eukaryotic peptides at the same
time. We did not fractionate samples to yield a bacterial pellet, as that would selectively detect
only those human proteins that are bound to bacterial cells [52]. Since changes of the host and
microbiome proteome are being examined at the same time, in theory our approach makes it
possible to investigate the mutualistic microbiome host relationship. Overall, the human KOs
identified mostly involved in nutrient digestion and the immune response, a result in agree-
ment with earlier metaproteomic studies [13,52]. On average, alpha-amylase, alkaline phos-
phatase and alpha 1 antitrypsin were the three top human proteins although there were
extensive variations between subjects and time points. All of these three proteins have been
linked to intestinal or extra-intestinal physiological conditions and they may also be one factor
contributing to the individuality of the microbiota as discussed below.
The levels of alpha-amylase may have an effect on the substrate availability for certain
microbial species living in the intestine. Recently, alpha-amylase was suggested to stimulate the
growth of vaginal Lactobacillus spp. [53] by breaking down glycogen. In contrast, Lactobacillus
strains from baby faeces have been found to exert inhibitory effects upon alpha-amylase and
other carbohydrate hydrolases [54]. Therefore, differences in alpha-amylase levels may be
reflections of different ecological niches favouring certain microbes. Alpha-amylase may also
have a protective effect in the intestine in the same way as has been observed in the mouth
where the enzyme inhibits the glucosyltransferase of Streptococcus mutans [55]. As observed in
this study, the amounts of alpha-amylase have been found to vary with time but also to be con-
sistently non-detectable in some individuals [13]. In a study of patients with diarrhea-type irri-
table bowel syndrome (IBS-D), elevated levels of tryptic activity and amylase were found [56].
Possibly there are higher levels of amylase during and after diarrhea as the rapid transit of
chyme might lead to a decreased (bacterial) degradation of this enzyme. The finding that indi-
vidual 104 had high levels of alpha-amylase after an episode of diarrhea is support for that
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hypothesis. In addition, other factors, such as diet, may have a role, since high alpha-amylase
levels were also observed in other individuals who did not report any intestinal symptoms.
Tryptic activity in faecal samples has been associated with intestinal disorders such as IBD
[57]. In general, proteinases have been intensively studied in the context of IBD and IBS [58].
The alpha 1 antitrypsin identified here may be involved in regulating the proteinase activities
and maintaining a balance of protein degradation in the intestine.
In faeces of mice fed a high fat diet, the levels of several mouse proteins such as alpha 1 anti-
trypsin were higher in parallel with less identified microbial proteins in comparison to mice
consuming a carbohydrate diet [59]. However, the same study also detected higher levels of
chymotrypsin B and there was speculation that the proteinase inhibitors may act also through
supplementary routes in addition to inhibiting proteinase activity. Therefore, the changes and
differences in the human proteins observed here might be due to a certain diet on a specific day
[60]. Alpha 1 antitrypsin has been associated with the treatment success of graft-vs.-host dis-
ease in GI transplantation in humans [61].
Alkaline phosphatase is a versatile enzyme [62]; in the gut it has been found to combat path-
ogen invasion into the intestinal epithelium [63]. In a mouse study, the presence of intestinal
alkaline phosphatase promoted the growth of a variety of intestinal bacteria [64]. Variations
between individuals in the levels of alkaline phosphatase have been detected previously [13];
here very high levels in one individual were found, and high levels of alkaline phosphatase were
mostly identified in those subjects who reported intestinal symptoms. Elevated levels of alka-
line phosphatase might be one way that compromised intestine attempts to restore equilib-
rium. It is tempting to speculate that the levels of this enzyme could be a marker of the
“quality” (intact, perturbed or somewhere in-between) of the host-microbe interaction.
DMBT1 (deleted in malignant brain tumor) was also one of the top 15 human KOs, its levels
were quite abundant in most individuals. As this is a healthy cohort, this result is not unex-
pected since it has been hypothesized that this protein, which is involved in host defence mech-
anisms, is indicative of a healthy intestine [52]. Many of the human KOs identified here
including alpha 1 antitrypsin, carboxypeptidase A1 and B, and alkaline phosphatase have been
found previously to be equally abundant throughout the intestinal tract when proteins at the
luminal interface were analysed [65], reflecting their crucial roles in intestinal activity.
Our results suggest that although over time variations in human KOs may be due to pathol-
ogy, diet and other environmental factors may also contribute to these variations. Inter-indi-
vidual differences may be influenced by different genetic backgrounds, both human and
microbial. It is evident that both human and bacterial proteins need to be studied to fully reveal
the mechanisms in the complex ecosystem of the intestine.
Conclusions
By analysing the proteins from faecal samples of 16 healthy individuals at three measurement
time points, the obtained metaproteome was found to contain a functional core but also to
show variation across individuals and with time. This study can be viewed as a first step
towards defining a healthy baseline, which is essential before one can evaluate the metapro-
teomes of diseased individuals, similar to the proposal concerning metagenomics [66].
A larger, well-stratified study cohort will be required to address the question of which
microbial composition leads to which metaproteomic phenotype, but based on our current
data, we conclude that different microbial profiles can lead to differences in the functionality of
the intestinal microbiota.
Assigning taxonomies to peptides revealed overall good correlations with the phylogenetic
data but caution is required, as presently it is difficult to estimate whether under- and over-
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representation of proteomic data is due to the actual biological activity of the microbes or to
experimental artefacts such as a (data) analysis bias (technical and annotation bias). Very few
studies have compared the composition of the microbiota and its actual functions being carried
out, but there is growing evidence that accessing the composition alone is not enough. It
appears that while the phylogenetic differences across samples are quite pronounced, metagen-
omes remain more stable. However, when evaluating the functions being expressed, then the
difference may again be larger.
Overall, the inter- and intra-individual differences appeared rather small at the level of COG
families. This indicates that with a stable proportion of main functionalities, there is a “healthy
balance”, e.g. in protein turnover and replication, in the intestinal ecosystem. Individual differ-
ences are more likely to be detected as one moves further down in the functional hierarchy.
This study is one step in the gradual exploration of the biological activity of our gut symbi-
onts. However, before we have a fundamental understanding of the crucial mechanisms pres-
ent in the intestine, it will be essential to clarify the functions of the many so far unidentified
proteins. In addition, functional classification systems have to be optimized for the human
microbiome. Overall, metaproteomics is still in its infancy and improvements, especially
regarding analytical depth and data analysis, are needed (e.g. in assigning peptides to protein
groups for quantitative comparisons) to fill in the large knowledge gaps which are an inherent
limitation of functional meta-omic analyses.
The combination of phylogenetic and metaproteomic data helps to gain a better under-
standing of the intestinal microbiota. For example, it reveals which microbes are living in the
intestine and how they contribute to the host’s metabolism including signalling to other bacte-
ria and signalling to the host. In the future, longitudinal studies will be required to clarify the
normal flux both in composition and biological activity of our microbes.
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